Macro International has informed that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 to consider and approve the Financial Result for the Quarter ended 31st December, 2019 in compliance with the requirements of Regulation 33 of the said Regulations. Pursuant to the Code of Conduct for Prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed from 1st January, 2020 till 48 hours after the commencement or declaration of Unaudited Financial Results for the quarter and nine months ended 31st December, 2019. A copy of notice of closure of trading window as submitted on 30th December, 2019 to the Stock Exchanges is attached for information.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: